10-K Decoder · All companies

Ocular Therapeutix, Inc.

OCUL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$52.0M$63.7M−18.5%
Operating income−$270M−$172M−57.2%
Net income−$266M−$194M−37.4%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$12.9M$14.5M−11.0%
Operating income−$97.9M−$68.7M−42.5%
Net income−$94.8M−$69.4M−36.6%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Ocular Therapeutix's revenue in FY2025?
$52.0M in FY2025 (Fiscal year ended Dec 31, 2025), −18.5% vs $63.7M a year earlier, per its 10-K filed Feb 2026.
Was Ocular Therapeutix profitable in FY2025?
No: net income was −$266M and operating income −$270M in FY2025.
What was Ocular Therapeutix's revenue in Q3 2026?
$12.9M (−11.0% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.